Frontlight ResearchEarly access
Ovarian cancer trials in China
185 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in ChinaA Study Evaluating the Diagnostic Performance of OCS in the Differential Diagnosis of Endometriosis vs. Endometriosis-Associated Ovarian Cancer
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 336
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07029659 - No phaseTaking peopleA Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
- Where
- Beijing
- Age
- 18 years and over
- People
- 1,000
- Run by
- Peking University Third Hospital
See details and how to joinNCT06564428 - Phase 1Taking peopleA Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 318
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT05740956 - Phase 1Taking peopleA Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 30
- Run by
- Weijia Fang, MD
See details and how to joinNCT05518253 - Phase 3Not yet taking people in ChinaSHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
- Where
- Wuhan
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Tongji Hospital
See details and how to joinNCT06990503 - Phase 1/2Not yet taking people in ChinaSHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer
- Where
- Wuhan
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Tongji Hospital
See details and how to joinNCT06990516 - Phase 2Not yet taking people in ChinaPhase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Fudan University
See details and how to joinNCT06973421 - Phase 2Taking peopleCombination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
- Where
- Wuhan
- Age
- 18 years and over
- People
- 150
- Run by
- Akeso
See details and how to joinNCT06686030 - Phase 2Taking peopleA Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 20
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06890858 - No phaseTaking peopleExploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 144
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06883487 - Phase 2/3Taking peoplePegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 296
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06791460 - Phase 2Taking peopleAn Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 172
- Run by
- Akeso
See details and how to joinNCT06560112 - Phase 1Not yet taking people in ChinaSCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 24
- Run by
- Shanghai Gynecologic Oncology Group
See details and how to joinNCT06846424 - No phaseNot yet taking people in ChinaImpact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer
- Where
- Hangzhou
- Age
- 20 years to 45 years
- People
- 300
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06845098 - Early phase 1Not yet taking people in ChinaAllogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 18
- Run by
- Peking University
See details and how to joinNCT06825455 - Phase 3Taking peopleNab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
- Where
- Guangzhou, Hangzhou, Ji'nan, Ningbo, Wenzhou
- Age
- 18 years to 75 years
- People
- 538
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05737303 - Phase 1/2Taking peoplePhase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 188
- Run by
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT06819215 - Phase 2Taking peopleSurgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
- Where
- Foshan, Guangzhou, Hangzhou, Hefei, Shanghai
- Age
- 18 years and over
- People
- 220
- Run by
- Shanghai Gynecologic Oncology Group
See details and how to joinNCT05200260 - No phaseTaking peopleUrinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
- Where
- Changsha
- Age
- 18 years and over
- People
- 240
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT06760923 - Phase 2Taking peopleFluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer
- Where
- Jinan
- Age
- 18 years and over
- People
- 105
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06735326 - No phaseTaking peoplePharmacokinetic Study of Tranexamic Acid
- Where
- Hangzhou
- Age
- 20 years to 64 years
- People
- 30
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06728670 - Phase 2Not yet taking people in ChinaA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 120
- Run by
- Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263 - Phase 1/2Taking peopleFuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
- Where
- Zhejiang
- Age
- 18 years to 70 years
- People
- 50
- Run by
- Xing Xie
See details and how to joinNCT04518501 - Phase 2Taking peopleSurufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer
- Where
- Hefei
- Age
- 18 years to 75 years
- People
- 74
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT06437353 - No phaseTaking peopleUltrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
- Where
- Hefei
- Age
- 18 years to 70 years
- People
- 70
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06640348